Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Argus Health
UBS
Johnson and Johnson
Healthtrust
US Army
Boehringer Ingelheim
Chubb
Baxter

Generated: January 24, 2019

DrugPatentWatch Database Preview

STATROL Drug Profile

« Back to Dashboard

When do Statrol patents expire, and when can generic versions of Statrol launch?

Statrol is a drug marketed by Alcon and is included in three NDAs.

The generic ingredient in STATROL is neomycin sulfate; polymyxin b sulfate. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the neomycin sulfate; polymyxin b sulfate profile page.

Summary for STATROL
US Patents:0
Applicants:1
NDAs:3
Formulation / Manufacturing:see details
DailyMed Link:STATROL at DailyMed
Drug patent expirations by year for STATROL

US Patents and Regulatory Information for STATROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon STATROL neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 050344-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alcon STATROL neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OPHTHALMIC 062339-001 Nov 30, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alcon STATROL neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OPHTHALMIC 050456-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Farmers Insurance
Express Scripts
US Army
Cantor Fitzgerald
McKinsey
Boehringer Ingelheim
Accenture
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.